Acquired resistance in mycobacterium avium complex strains isolated from AIDS patients and beige mice daring treatment with clarithromycin

Florence Doucet-populaire, Chantal Truffot-pernot, Jacques Grosset, Vincent Jarlier

Research output: Contribution to journalArticlepeer-review

Abstract

Clarithromycin has been reported to select clarithromycin resistant mutants of Mycobacterium avium complex (MAC) during treatment with clarithromycin in AIDS patients and beige mice. We selected resistant mutants in vitro at a frequency of 5 × 10-9. Clarithromycin resistant strains of MAC isolated in AIDSpatients and beige mice as well as derivatives selected in vitro had a unique pattern of acquired cross-resistance to macrolides and related antibiotics. In contrast, the pattern of resistance to non-macrolide antibiotics remained unchanged in clarithromycin resistant strains. A dramatic decrease in ribosome affinity for clarithromycin and erythromycin was found in clarithromycin resistant strains, but no mutation was found in the peptidyl domain of the 23S rRNA, indicating that another ribosomal modification is involved.

Original languageEnglish (US)
Pages (from-to)129-136
Number of pages8
JournalJournal of Antimicrobial Chemotherapy
Volume36
Issue number1
DOIs
StatePublished - Jul 1995

ASJC Scopus subject areas

  • Pharmacology
  • Microbiology (medical)
  • Infectious Diseases
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Acquired resistance in mycobacterium avium complex strains isolated from AIDS patients and beige mice daring treatment with clarithromycin'. Together they form a unique fingerprint.

Cite this